Kevin C. Tang, Director, 10% Owner at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 150,000 shares at $19.30 ($3.1M) on 2015-06-01, disclosed to the SEC on 2015-06-02.
Open-market purchase of $3.1M HRTX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.74 | 115,225 | $2.3M | 73.5% |
| 2 | $19.30 | 2,380 | $46K | 1.5% |
| 3 | $23.84 | 32,395 | $772K | 25.0% |
| Total | $20.62 avg | 150,000 | $3.1M | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |